Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	49.93	31.25	20.85
Graham Fair Price	41.43	1.03	0.73
PEG	-76.44	0.04	-0.17
Price/Book	-13.85	0.41	0.48
Price/Cash Flow	74.28	-15.38	-59.78
Prices/Earnings	-56.92	4.02	9.33
Price/Sales	-56.92	7.04	16.35
Price/FCF	74.28	-15.38	-59.78
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.56	0.56
Operating Margin	-70.48	0.45	1.51
ROA	100.00	0.02	< 0.005
ROE	0.01	0.03	100.00
ROIC	0.02	0.01	-40.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	< 0.005	-90.78
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.05	-0.41	-791.90
EPS QOQ	-0.55	1.00	82.86
FCF QOQ	-1.10	-2.35	-114.41
Revenue QOQ	-0.61	1.00	65.10
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	9.30	4.65	-50.00
Days Sales Outstanding (DSO)	1772.38	928.03	-47.64
Inventory Turnover	9.68	19.36	100.00
Debt/Capitalization	0.34	0.34	0.05
Quick Ratio	2.86	2.98	4.23
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.36	1.36	< 0.005
Cash	0.09	0.09	< 0.005
Capex	< 0.005	< 0.005	-100.01
Free Cash Flow	-0.01	-0.04	-234.95
Revenue	0.04	0.08	100.01
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	3.00	3.00	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.20	16.47	61.41
Naive Interpretation	Member

06 - Financial Health · Bad

Rating